|
|
|
|
|
|
Use of and attitudes towards the prescribing guidelines booklet in primary health care doctors
Magnus AB Axelsson, Malin Spetz, Anders Mellén, Susanna M Wallerstedt BMC Clinical Pharmacology 2008, 8:8 (22 September 2008)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Long-term platinum retention after treatment with cisplatin and oxaliplatin
Elke EM Brouwers, Alwin DR Huitema, Jos H Beijnen, Jan HM Schellens BMC Clinical Pharmacology 2008, 8:7 (17 September 2008)
Abstract | Full text | PDF
| PubMed
|
Editor’s summary
Chemotherapy with platinum compounds results in retention of the metal in plasma, partly in a reactive form, but it remains unclear what long term consequences this has for the patient.
|
|
|
|
Antihypertensive drug class and impaired fasting glucose: a risk association study among Chinese patients with uncomplicated hypertension
Martin CS Wong, Johnny Y Jiang, H Fung, Sian Griffiths, Stewart Mercer BMC Clinical Pharmacology 2008, 8:6 (10 September 2008)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Optimizing bioavailability of oral administration of small peptides through pharmacokinetic and pharmacodynamic parameters: The effect of water and timing of meal intake on oral delivery of Salmon Calcitonin
Morten A Karsdal, Inger Byrjalsen, Bente J Riis, Claus Christiansen BMC Clinical Pharmacology 2008, 8:5 (9 September 2008)
Abstract | Full text | PDF
| PubMed
|
|
|
|
The Clinical Pharmacology of Intranasal l-Methamphetamine
John E Mendelson, Dana McGlothlin, Debra S Harris, Elyse Foster, Tom Everhart, Peyton Jacob, Reese T Jones BMC Clinical Pharmacology 2008, 8:4 (21 July 2008)
Abstract | Full text | PDF
| PubMed
|
Editor’s summary
Over-the-counter nasal sprays containing l-methamphetamine, an isomer of the highly addictive drug d-methamphetamine, do not produce major dose-dependent psychological effects, and produce only minor changes in blood pressure.
|
|
|
|
Evaluation of safe and effective administration of nitrous oxide after a postgraduate training course
Valérie Collado, Emmanuel Nicolas, Denise Faulks, Corinne Tardieu, Marie-Cécile Manière, Dominique Droz, Peter Onody, Martine Hennequin BMC Clinical Pharmacology 2008, 8:3 (11 June 2008)
Abstract | Full text | PDF
| PubMed
|
Editor’s summary
Training dentists in conscious sedation enables safe and effective administration of a 50% nitrous oxide in oxygen premix, but additional training in behavior management is needed to sedate patients with intellectual disability.
|
|
|
|
Renal safety of zoledronic acid with thalidomide in patients with myeloma: a pharmacokinetic and safety sub-study
Andrew Spencer, Andrew Roberts, Nola Kennedy, Christina Ravera, Serge Cremers, Sanela Bilic, Terry Neeman, Michael Copeman, Horst Schran, Kevin Lynch BMC Clinical Pharmacology 2008, 8:2 (31 March 2008)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Individual case safety reports in children in commonly used drug groups – signal detection
Gertrud Brunlöf, Carina Tukukino, Susanna M Wallerstedt BMC Clinical Pharmacology 2008, 8:1 (17 March 2008)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption – an individual-level prescription database study
Ingeborg Hartz, Solveig Sakshaug, Kari Furu, Anders Engeland, Anne Eggen, Inger Njølstad, Svetlana Skurtveit BMC Clinical Pharmacology 2007, 7:14 (5 December 2007)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
|
Antimalarial activity of the anticancer and proteasome inhibitor bortezomib and its analog ZL3B
Jennifer M Reynolds, Kamal El Bissati, Jens Brandenburg, Arthur Günzl, Choukri Mamoun BMC Clinical Pharmacology 2007, 7:13 (23 October 2007)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Influence of an e-mail with a drug information attachment on sales of prescribed drugs: a randomized controlled study
Christina Edward, Anders Himmelmann, Susanna M Wallerstedt BMC Clinical Pharmacology 2007, 7:12 (18 October 2007)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
|
Pharmacokinetics, safety and efficacy from randomized controlled trials of 1 and 2 mg nicotine bitartrate lozenges (Nicotinell®)
Bertrand Dautzenberg, Mitchell Nides, Jean-Luc Kienzler, Anne Callens BMC Clinical Pharmacology 2007, 7:11 (8 October 2007)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Pharmacokinetics of recombinant human growth hormone administered by cool.click™ 2, a new needle-free device, compared with subcutaneous administration using a conventional syringe and needle
Chris Brearley, Anthony Priestley, James Leighton-Scott, Michel Christen BMC Clinical Pharmacology 2007, 7:10 (8 October 2007)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
|
Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998–2005
Hitesh Patel, Derek Bell, Mariam Molokhia, Janakan Srishanmuganathan, Mitesh Patel, Josip Car, Azeem Majeed BMC Clinical Pharmacology 2007, 7:9 (25 September 2007)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
|
Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study
KJ Patel, MS Kedia, D Bajpai, SS Mehta, NA Kshirsagar, NJ Gogtay BMC Clinical Pharmacology 2007, 7:8 (28 July 2007)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
|
Expression of thymidine phosphorylase in peripheral blood cells of breast cancer patients is not increased by paclitaxel
Rupert Bartsch, Guenther G Steger, Birgit Forstner, Catharina Wenzel, Ursula Pluschnig, Blanka Rizovski, Gabriela Altorjai, Christoph C Zielinski, Robert M Mader BMC Clinical Pharmacology 2007, 7:7 (18 July 2007)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Phenotype-genotype analysis of CYP2C19 in Colombian mestizo individuals
Carlos Isaza, Julieta Henao, José Martínez, Juan Arias, Leonardo Beltrán BMC Clinical Pharmacology 2007, 7:6 (11 July 2007)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls
Pekka Rapeli, Carola Fabritius, Hannu Alho, Mikko Salaspuro, Kristian Wahlbeck, Hely Kalska BMC Clinical Pharmacology 2007, 7:5 (12 June 2007)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
|
Does atenolol differ from other β-adrenergic blockers?
Ivar Aursnes, Jan-Bjørn Osnes, Ingunn Tvete, Jørund Gåsemyr, Bent Natvig BMC Clinical Pharmacology 2007, 7:4 (8 May 2007)
Abstract | Full text | PDF
| PubMed
|
Editor’s summary
Hypertensive people taking non-atenolol beta blockers have a significantly lower risk of myocardial infarction than those taking atenolol, suggesting that atenolol is not a typical member of the beta blocker class of drugs.
|
|
|
|
Pharmacokinetic investigation of dose proportionality with a 24-hour controlled-release formulation of hydromorphone
Gayatri Sathyan, Emily Xu, John Thipphawong, Suneel K Gupta BMC Clinical Pharmacology 2007, 7:3 (2 February 2007)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Pharmacokinetic profile of a 24-hour controlled-release OROS® formulation of hydromorphone in the presence and absence of food
Gayatri Sathyan, Emily Xu, John Thipphawong, Suneel K Gupta BMC Clinical Pharmacology 2007, 7:2 (2 February 2007)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
|
Heterogeneity of human adipose blood flow
David G Levitt BMC Clinical Pharmacology 2007, 7:1 (20 January 2007)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
|
Evaluation of the activity of CYP2C19 in Gujrati and Marwadi subjects living in Mumbai (Bombay)
Tanmay S Panchabhai, Shaun F Noronha, Sanish Davis, Vishal M Shinde, Nilima A Kshirsagar, Nithya J Gogtay BMC Clinical Pharmacology 2006, 6:8 (24 October 2006)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Finasteride induced depression: a prospective study
Babak Rahimi-Ardabili, Ramin Pourandarjani, Peiman Habibollahi, Amir Mualeki BMC Clinical Pharmacology 2006, 6:7 (7 October 2006)
Abstract | Full text | PDF
| PubMed |
|
|
|
|
Accumulation of the solvent vehicle sulphobutylether beta cyclodextrin sodium in critically ill patients treated with intravenous voriconazole under renal replacement therapy
Marc A von Mach, Jürgen Burhenne, Ludwig S Weilemann BMC Clinical Pharmacology 2006, 6:6 (18 September 2006)
Abstract | Full text | PDF
| PubMed |
|